[Cephacetrile (C 36278-Ba), a new antibiotic of the cephalosporin group. Pharmacokinetics and clinical investigation].
D000081:Acetamides / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use; D000653:Amniotic Fluid / Q000378:metabolism; D001646:Bile / Q000378:metabolism; D002511:Cephalosporins / Q000009:adverse effects / Q000378:metabolism* / Q000627:therapeutic use; D003404:Creatinine / Q000378:metabolism; D004341:Drug Evaluation; D004927:Escherichia coli Infections / Q000188:drug therapy; D006207:Half-Life; D006801:Humans; D008297:Male; D009570:Nitriles / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use; D010019:Osteomyelitis / Q000378:metabolism; D011008:Pneumococcal Infections / Q000188:drug therapy; D011467:Prostate / Q000378:metabolism; D011512:Proteus Infections / Q000188:drug therapy; D012141:Respiratory Tract Infections / Q000188:drug therapy; D013203:Staphylococcal Infections / Q000188:drug therapy; D013290:Streptococcal Infections / Q000188:drug therapy; D014552:Urinary Tract Infections / Q000188:drug therapy
D000081:Acetamides; D002511:Cephalosporins; D009570:Nitriles; D003404:Creatinine
Cephacetril (C 36278-Ba), ein neues Antibiotikum aus der Cephalosporinreihe. Pharmakokinetik und klinische Prüfung